PH21581A - B-lactams and process for preparing the same - Google Patents

B-lactams and process for preparing the same

Info

Publication number
PH21581A
PH21581A PH27783A PH27783A PH21581A PH 21581 A PH21581 A PH 21581A PH 27783 A PH27783 A PH 27783A PH 27783 A PH27783 A PH 27783A PH 21581 A PH21581 A PH 21581A
Authority
PH
Philippines
Prior art keywords
lactams
manufacture
readily cleavable
group
amino
Prior art date
Application number
PH27783A
Other languages
English (en)
Inventor
Hubschwerlen Dr Christ Nicolas
Schmid Dr Gerard
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH21581A publication Critical patent/PH21581A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Fats And Perfumes (AREA)
PH27783A 1981-08-27 1982-08-26 B-lactams and process for preparing the same PH21581A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH552481 1981-08-27
CH392582 1982-06-25

Publications (1)

Publication Number Publication Date
PH21581A true PH21581A (en) 1987-12-11

Family

ID=25694185

Family Applications (1)

Application Number Title Priority Date Filing Date
PH27783A PH21581A (en) 1981-08-27 1982-08-26 B-lactams and process for preparing the same

Country Status (15)

Country Link
US (3) US4576751A (fr)
EP (2) EP0073061B1 (fr)
KR (1) KR880000432B1 (fr)
AT (2) ATE30017T1 (fr)
AU (2) AU555097B2 (fr)
CA (1) CA1262128A (fr)
DE (2) DE3275543D1 (fr)
DK (1) DK168433B1 (fr)
ES (1) ES515255A0 (fr)
HU (1) HU190697B (fr)
IE (1) IE53791B1 (fr)
IL (1) IL66619A0 (fr)
NO (1) NO159931C (fr)
NZ (1) NZ201660A (fr)
PH (1) PH21581A (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782147A (en) * 1980-12-05 1988-11-01 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
US4572801A (en) * 1981-04-30 1986-02-25 Takeda Chemical Industries, Ltd. 4-Carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
DE3372768D1 (de) * 1982-06-03 1987-09-03 Hoffmann La Roche 1-sulfo-2-oxoazetidine derivatives
CA1204746A (fr) * 1982-08-19 1986-05-20 Hoffmann-La Roche Limited Beta-lactams
US4663469A (en) * 1982-12-09 1987-05-05 Hoffman-La Roche Inc. 4-hydroxy-l-threoninamides
US4502994A (en) * 1982-12-09 1985-03-05 Hoffmann-La Roche Inc. Enantiomeric synthesis of 3-amino-4-carbamoyloxymethyl-2-azetidonone-1-sulfate
CA1251454A (fr) * 1983-01-20 1989-03-21 Gerard Schmid PROCEDE DE PRODUCTION DE .beta.-LACTAMES
DK36784A (da) * 1983-02-25 1984-08-26 Hoffmann La Roche Fremgangsmaade til fremstilling af chirale aldehyder
US4501697A (en) * 1983-06-17 1985-02-26 E. R. Squibb & Sons, Inc. 4-[[(Amidomethyl)oxy]methyl]-2-oxo-1-azetidinesulfonic acid salts
DK411384A (da) * 1983-10-03 1985-04-04 Hoffmann La Roche Fremgangsmaade til fremstilling af azetidinonderivater
EP0146735A1 (fr) * 1983-11-23 1985-07-03 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Bêta-lactames optiquement uniformes
JPS60139667A (ja) * 1983-12-27 1985-07-24 Takeda Chem Ind Ltd アゼチジノンの製造法
GB8717446D0 (en) * 1987-07-23 1987-08-26 Merck Sharp & Dohme Chemical compounds
US4937331A (en) * 1988-03-25 1990-06-26 President And Fellows Of Harvard College Chiral azetidinone epoxides
ES2419255T3 (es) * 2007-09-17 2013-08-20 Basilea Pharmaceutica Ag Procedimiento para la fabricación de intermediarios monobactamo puenteados
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
CN103044416A (zh) * 2012-12-17 2013-04-17 浙江华方药业有限责任公司 一种卡芦莫南钠的合成方法
LT3122745T (lt) 2014-03-24 2019-04-10 Novartis Ag Monobaktamo organiniai junginiai, skirti bakterinių infekcijų gydymui
WO2017050218A1 (fr) 2015-09-23 2017-03-30 Novartis Ag Sels et formes solides d'antibiotique monobactame
US11414411B2 (en) 2017-08-02 2022-08-16 Novartis Ag Chemical process for manufacturing monobactam antibiotic and intermediates thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK194776A (da) * 1975-05-05 1976-11-06 Smithkline Corp Antibakterielle midler og mellemprodukter dertil
GB1570278A (en) * 1975-10-06 1980-06-25 Fujisawa Pharmaceutical Co O-substituted-2-azetidinone derivatives and the preparation thereof
JPS609514B2 (ja) * 1976-08-05 1985-03-11 塩野義製薬株式会社 7−アミノ−3′−ノルセファロスポラン酸類
US4202978A (en) * 1978-02-08 1980-05-13 Hoffmann-La Roche Inc. (S)-1-[2-(4-(2-Hydroxy-s-(1-alkylaminopropoxy)phenylalkyl]-4-phenylpiperazines
US4473502A (en) * 1981-04-08 1984-09-25 Merck & Co., Inc. Synthesis of thienamycin via (3SR, 4RS)-3-[1 (SR)-hydroxyethyl]-2-oxo-4-azetidineacetic acid

Also Published As

Publication number Publication date
KR840001135A (ko) 1984-03-28
DK373082A (da) 1983-02-28
EP0073061B1 (fr) 1987-03-04
DE3277410D1 (en) 1987-11-05
US4576751A (en) 1986-03-18
EP0073061A2 (fr) 1983-03-02
IE822067L (en) 1983-02-27
AU5467186A (en) 1986-07-31
EP0073061A3 (en) 1983-06-15
DK168433B1 (da) 1994-03-28
ATE30017T1 (de) 1987-10-15
US4699986A (en) 1987-10-13
AU576951B2 (en) 1988-09-08
IE53791B1 (en) 1989-02-15
EP0156976B1 (fr) 1987-09-30
NO822902L (no) 1983-02-28
EP0156976A3 (en) 1986-06-04
ES8401935A1 (es) 1984-01-16
ES515255A0 (es) 1984-01-16
AU8752382A (en) 1983-03-03
NZ201660A (en) 1986-01-24
US4617150A (en) 1986-10-14
AU555097B2 (en) 1986-09-11
DE3275543D1 (en) 1987-04-09
ATE25676T1 (de) 1987-03-15
NO159931C (no) 1989-02-22
HU190697B (en) 1986-10-28
EP0156976A2 (fr) 1985-10-09
KR880000432B1 (ko) 1988-03-24
CA1262128A (fr) 1989-10-03
IL66619A0 (en) 1982-12-31
NO159931B (no) 1988-11-14

Similar Documents

Publication Publication Date Title
PH21581A (en) B-lactams and process for preparing the same
CA2083041A1 (fr) Composes marques utilises pour un test respiratoire diagnostique
DE3587546D1 (de) Verfahren zur Herstellung von optisch aktiven Acyloxyazetidinonen.
ATE37711T1 (de) 1,3,4,5-tetrahydrobenz(c,d>indole, ein verfahren zu ihrer herstellung und ihre verwendung.
ATE137238T1 (de) Beta-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
ES2004079A6 (es) Procedimiento para la preparacion de derivados aminicos antimicoticos y agrofungicidas
DE69416424T2 (de) Verfahren zur herstellung von tert-leucin und analoge in enantiemerer form und zwischenprodukte
SE7501375L (fr)
FR2383995B1 (fr)
ES489251A1 (es) Procedimiento para la preparacion de deacetoxicefalosporinasbromo-sustituidas
ES8106324A1 (es) Procedimiento para preparar colorantes monoazoicos dispersos
ES470161A1 (es) Procedimiento para la preparacion de nuevos colorantes an- traquinonicos solubles en agua
ES8306756A1 (es) Un procedimiento para la preparacion de un enantiomero de beta-lactama.
NO880752L (no) Fremgangsmaate for fremstilling av diorganosiloksanholdigediaminer.
CH614730A5 (fr)
ES8201193A1 (es) Procedimiento para la preparacion de colorantes fibrorreac- tivos
GB1477073A (en) Reactive phenazine dyestuffs